Evidence from another animal study supports that CGA increases intestinal uric acid excretion by affecting the levels of intestinal urate transporters (ABCG2, GLUT9), combating hyperuricemia (Mehmood et al., 2019). The gene discussed is ABCG2; the disease is hyperuricemia.